Skip to content

Clinical trials

Lipid Metabolism Disorders trials in China

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Lipid Metabolism Disorders Country / region: China Clear all

17 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20111
20121
20131
20161
20192
20202
20211
20223
20231
20243
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed7
Unknown status6
Recruiting3
Not yet recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Capital Medical University1
China-Japan Friendship Hospital1
Chongqing Medical University1
Heart Health Research Center1
Hepatopancreatobiliary Surgery Institute of Gansu Province1
Nanjing Medical University1
Novartis Pharmaceuticals1
OmniSolutions Laboratory Holdings Limited1
RenJi Hospital1
Shandong Provincial Hospital1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Lipid Metabolism Disorders17
Glucose Metabolism Disorders5
Diabetes Mellitus, Type 23
Dyslipidemias2
Obesity2
Arteriosclerosis1
Atherosclerosis1
Coronary Artery Disease1
Coronary Disease1
Diabetes Mellitus1

Trials

Showing 26 to 17 of 17. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.